$TSBK Cashflow Statement | Understand Stock

$TSBK

$47.90 +$1.00 (2.13%) Close

$TSBK Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated Statements of Cash Flows

In millions of USD, except per-share amounts

	FY2025 12 months to Sep 30, 2025	FY2024 12 months to Sep 30, 2024	FY2023 12 months to Sep 30, 2023	FY2022 12 months to Sep 30, 2022	FY2021 12 months to Sep 30, 2021
Cash flows from operating activities
Net income
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation
Deferred income taxes
Amortization of CDI
Earned ESOP shares
Accretion of discount on purchased loans
Stock-based compensation expense
Gain on sales of investment securities, net
Net recoveries on investment securities
Change in fair value of investments in equity securities
Gain on sales of OREO and other repossessed assets, net
Accretion of discounts and premiums on securities
Provision for OREO losses
Gain on sales of loans, net
Gain on sales/dispositions of premises and equipment, net
Total provision for credit losses - net
Loans originated for sale
Proceeds from sales of loans
Amortization of loan servicing rights
Valuation adjustment on loan servicing rights, net
BOLI net earnings
BOLI death benefit in excess of cash surrender value
Increase in deferred loan origination fees
Net change in accrued interest receivable and other assets, and other liabilities and accrued expenses

Net cash provided by operating activities
Cash flows from investing activities
Net decrease in CDs held for investment
Purchase of investment securities held to maturity
Purchase of investment securities available for sale
Proceeds from maturities and prepayments of investment securities held to maturity
Proceeds from maturities and prepayments of investment securities available for sale
Proceeds from sale of investment securities held to maturity
Proceeds from sales of investment securities available for sale
Purchase of FHLB stock
Proceeds from redemption of FHLB stock
Increase in loans receivable, net
Purchase of premises and equipment
Proceeds from sales of OREO and other repossessed assets
Proceeds from sales/dispositions of premises and equipment
Proceeds from death benefit on BOLI
Cash acquired, net of cash consideration paid in business combination
Escrow deposit for business combination
Net cash used in investing activities

Cash flows from financing activities
Net increase (decrease) in deposits
Proceeds from (repayment of) FHLB borrowings
(Repayment of) proceeds from FHLB borrowings
Proceeds from exercise of stock options
Repurchase of common stock, net of tax
Payment of dividends
Net cash provided by (used in) financing activities
Net increase (decrease) in cash and cash equivalents
Beginning of year
End of year
Supplemental disclosure of cash flow information
Income taxes paid
Interest paid
Supplemental disclosure of non-cash investing and financing activities
Loans transferred to OREO and other repossessed assets
Other comprehensive (loss) income related to investment securities
Operating lease liabilities arising from recording of ROU assets
Adjustment to retained earnings, net of deferred tax - adoption of ASU 2016-13
Shareholders’ equity

Comments